SCHEMBL8157619

SCHEMBL8157619

CC(C)(C)[Si](OC[C@@H]1CO[C@H](COC(=O)c2ccccc2)O1)(c1ccccc1)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.39
ALDH1A1 P00352 2/20 0.38
CHRNB2 P17787 1/20 0.37
CHRNA5 P30532 1/20 0.37
CHRNA7 P36544 1/20 0.37
CHRNA4 P43681 1/20 0.37
CES2 O00748 1/20 0.36
SMYD2 Q9NRG4 2/20 0.36
CYP3A4 P08684 1/20 0.36
HTT P42858 1/20 0.36
PPM1B O75688 1/20 0.35
MEN1 O00255 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C19 P33261 1/20 0.35
KMT2A Q03164 1/20 0.35
LMNA P02545 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MAPK1 P28482 1/20 0.35
HIF1A Q16665 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13866342 0.84 NPC1 (0.44) NPC1ALDH1A1CHRNB2CHRNA5CHRNA7
SCHEMBL8166048 0.83 SMYD2 (0.38) ALDH1A1SMYD2CYP3A4HTTMEN1
SCHEMBL9886817 0.79 MEN1 (0.47) ALDH1A1SMYD2CYP3A4HTTMEN1
SCHEMBL20500291 0.79 MEN1 (0.47) ALDH1A1SMYD2CYP3A4HTTMEN1
SCHEMBL7203588 0.79 MEN1 (0.47) ALDH1A1SMYD2CYP3A4HTTMEN1
SCHEMBL5426737 0.78 NPC1 (0.44) NPC1ALDH1A1CHRNB2CHRNA5CHRNA7
SCHEMBL1930298 0.77 NPC1 (0.43) NPC1ALDH1A1CHRNB2CHRNA5CHRNA7
SCHEMBL7187471 0.77 NPC1 (0.43) NPC1ALDH1A1CHRNB2CHRNA5CHRNA7
SCHEMBL7782571 0.77 NPC1 (0.43) NPC1ALDH1A1CHRNB2CHRNA5CHRNA7
SCHEMBL5213230 0.77 NPC1 (0.43) NPC1ALDH1A1CHRNB2CHRNA5CHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6110923-A Method for treating cancer using novel substituted purinyl derivatives with immunomodulating activity BIOCHEM PHARMA INC. (CA) 2000-08-29 US disclosed
US-5994361-A ANTITUMOR, ANTICANCER AGENT BIOCHEM PHARMA (CA) 1999-11-30 US disclosed
EP-0766683-A1 NOVEL SUBSTITUTED PURINYL DERIVATIVES WITH IMMUNOMODULATING ACTIVITY BIOCHEM PHARMA INC (CA) 1997-04-09 EP disclosed
WO-1995035297-A1 NOVEL SUBSTITUTED PURINYL DERIVATIVES WITH IMMUNOMODULATING ACTIVITY BIOCHEM PHARMA INC. (CA) 1995-12-28 WO disclosed